Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: In February 2020, conservative radio host Rush Limbaugh announced that he had been diagnosed with lung cancer. While U.S. President Donald Trump honored the controversial commentator with the Presidential Medal of Freedom, some social media users noted that Limbaugh had a history of making demeaning comments on his program. For instance, one widely shared video clip supposedly showed Limbaugh mocking actor Michael J. Fox and claiming that he was "exaggerating" symptoms of his Parkinson's disease. Just A Quick Reminder Of The Time Rush Limbaugh Mocked Michael J. Fox's Parkinson's By Pretending To Shake Uncontrollably. pic.twitter.com/dX3L0jtnUv Austin (@austin63867) February 3, 2020 This is a genuine clip of Limbaugh describing Fox on his program. Media Matters archived the full audio of this segment, which originally aired during an Oct. 23, 2006, episode of Limbaugh's radio show. Here's a partial transcript of the segment: In this commercial he is exaggerating the effects of the disease. He is moving all around and shaking and it's purely an act. This is the only time I've ever seen Michael J. Fox portray any of the symptoms of the disease he has. He can control himself to keep himself in the frame of the picture. And he can control himself enough to keep his eyes right on the lens, the teleprompter. But his head and shoulders are moving all over the place. This is really shameless, folks. This is really shameless of Michael J. Fox. Either he didn't take his medication or he's acting. Fox, who is probably best known for playing young conservative Alex P. Keaton on the show "Family Ties" and the time-traveling high school student Marty McFly in the "Back to the Future" series, was diagnosed with Parkinson's disease in 1991. In 2006, he filmed a 30-second ad for former Democratic U.S. Sen. Claire McCaskill and her support of stem cell research: Limbaugh was commenting on this advertisement in the above-displayed clip. The segment stirred considerable controversy at the time and even drew an apology from Limbaugh. The Guardian reported: "Hours later the talkshow host was forced to retract. 'I will bigly, hugely admit that I was wrong. '" While Limbaugh initially apologized, he would later say on his show that he never made fun of Fox and that this controversy was created by the "drive-by" media. Limbaugh also renewed attacks on Fox and said that the actor was "allowing his illness to be exploited" and was "shilling for a Democratic politician." The Washington Post reported: After his apology, Limbaugh shifted his ground and renewed his attack on Fox. "Now people are telling me they have seen Michael J. Fox in interviews and he does appear the same way in the interviews as he does in this commercial," Limbaugh said, according to a transcript on his Web site. "All right then, I stand corrected. . . . So I will bigly, hugely admit that I was wrong, and I will apologize to Michael J. Fox, if I am wrong in characterizing his behavior on this commercial as an act." Claim: "Radio host Rush Limbaugh once claimed that actor Michael J. Fox was ""exaggerating"" his Parkinson's disease symptoms in a political ad."

A: Then Limbaugh pivoted to a different critique: "Michael J. Fox is allowing his illness to be exploited and in the process is shilling for a Democratic politician."
****
Q: Paragraph: The story devotes its second paragraph to cost, including how that cost may differ depending on whether patients have insurance. Well done. This is a really close one. The story does a lot of things well here. It notes that, in one trial, there was no difference in the benefits between Xofluza and existing flu treatment drug oseltamivir (better known as Tamiflu). However, it does not actually quantify the benefits associated with Xofluza. Instead, the story states that it "may alleviate some symptoms and shorten the time patients feel sick." We approve of the cautious language used throughout the story, but we like to see quantified benefits in instances where the information is available. In this case, an article published in the New England Journal of Medicine in September reported that Xofluza reduced the "time to alleviation of symptoms" by a mean of 25-38 hours, compared to placebo (the difference depended on the age group of the patient). Ergo, a not satisfactory rating here. The story addresses this issue head on, earning it a solid satisfactory rating from us. One point that would have made it even stronger would have been to note that the company selling Xofluzawarns that pregnant women and nursing mothers may want to avoid the drug, as it is not known whether the drug may harm the fetus or if it would pass into breastmilk for nursing mothers. The story does a good job of describing the supporting evidence clearly and concisely. No disease mongering here. In fact, the story provides good context on the risks posed by influenza. The story incorporates input from two sources at the FDA, but the information appears to stem from an FDA statement. Information from pharmaceutical companies is clearly marked, but we really look for news stories to incorporate input from independent sources beyond what may be available in a news release. The story addresses the similarities (and differences) to other drugs that address flu symptoms, particularly oseltamivir (Tamiflu). The story notes that Xofluza has received FDA approval. As noted above, the drugs similarities and differences to existing pharmaceutical treatment options was laid out clearly. The news peg here was FDA's approval of the drug, which is also made clear. The work goes well beyond what you would find in any news release. We particularly applaud the story's discussion of viruses developing resistance to antiviral drugs. Claim: F.D.A. Approves New Drug for Flu

A: This story is one of two we are reviewing that focuses on FDA's approval of a drug designed to speed patient recovery from flu symptoms (the second story is from ABC News). The drug is baloxavir marboxil, marketed under the trade name Xofluza. This New York Times story hits most of the points that we want to see in a story about a new drug. The criteria that we use at HealthNewsReview.org to review health-related news stories were not developed in a vacuum. Rather, these are the criteria we feel are essential to allow patients and health care providers to make informed decisions about diagnosis and treatment options. While we do ding it on a couple things, the story does not exaggerate the findings, and provides people with the fundamental details they need to be informed patients. We were especially pleased that this story did not perpetuate misinformation that's developed around this drug that is, that it could help reduce transmission of the virus. To date, there is no evidence to show that as a benefit.
****
Q: Paragraph: KDVR-TV reported Monday that three of the cases were diagnosed within the past three weeks. Denver Public Health executive director Dr. Bill Burman says his agency will set up vaccine clinics almost every day in day shelters, syringe access programs, Civic Center Park and other places where people at risk of contracting the disease are found. Hepatitis A can be spread through sharing of drugs and equipment, fecal-oral contamination or intimate contact with a person who has the disease. Health officials say the disease can be prevented with a vaccine that's been a part of standard childhood immunizations for more than a decade. ___ Information from: KDVR-TV, http://www.kdvr.com Claim: 4 hepatitis A cases found in Denver; vaccinations stepped up.

A:
Denver public health officials say four homeless people have been diagnosed with hepatitis A this year, so the city is stepping up free vaccinations.
****